This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elsevier And The American College Of Cardiology Announce The Launch Of A New Journal JACC: Heart Failure

Stocks in this article: ENL RUK

NEW YORK, March 5, 2013 /PRNewswire/ --

First publication now available online

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the American College of Cardiology (ACC) are pleased to announce that the American College of Cardiology (ACC ) journals' portfolio has been expanded with the launch of JACC: Heart Failure. This new journal will better meet the demands and challenges of treating what is now the most rapidly increasing category of cardiac disease. The first publication is now available online at heartfailure.onlinejacc.org.

Christopher O'Connor, MD, FACC will serve as Editor-in-Chief of JACC: Heart Failure. Each bi-monthly issue will present high-quality content, authored by experts worldwide, with a unique focus on new research and treatment options. It is destined to take its place among the top journals in the world for the understanding of the pathophysiology, diagnosis, treatment, and care of heart failure patients with the intent to improve our understanding of the disease, clinical trials, clinical outcomes, and advances in therapies through scientific communication.

A state-of-the-condition update by Dr. Eugene Braunwald and the breadth of articles featured in the first issue are an example of the journal's aims to publish the full range of topics related to this condition - including basic and translational science, trials and registries, co-morbidities, biomarkers, advanced heart failure, and outcomes.

"The addition of JACC: Heart Failure to ACC's current portfolio will help meet the need for more research in this growing field," said ACC President William Zoghbi, MD, FACC. "With the increasing rate of patients suffering from heart failure, the science presented in this new journal will give cardiologists access to valuable new research."

"We are delighted to be publishing JACC: Heart Failure in collaboration with the ACC," says Cynthia Baudendistel, Executive Publisher for the ACC journals at Elsevier. "We look forward to seeing the impact this journal will make on cardiology practice, research, teaching, and advocacy."

For more information or to submit an article, go to: heartfailure.onlinejacc.org or jaccsubmit-heartfailure.org

About the American College of Cardiology (ACC)

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs